Figure 2

Efficacy of gentamicin. The probability of cure following treatment with gentamicin compared to cure with a comparator antibiotic. The probability of cure was comparable between gentamicin and comparator antibiotics. TMPSMX trimethoprim/sulphamethoxazole, APC amoxicillin, probenecid and clavunate, APC-D amoxicillin, probenecid, clavunate and doxycycline. Risk ratios: Lule (TMPSMX) 1.9679 (95% CI 1.3412-2.8873); Lule (APC-D) 1.0231 (95%CI 0.924201.1325); Lule (APC) 1.4250 (95% CI 1.1754-1.7275); Lule (ciprofloxacin) 1.0191 (95% CI 0.9231-1.1251); Pareek (specinomycin) 1.1875 (95% CI 0.9331-1.5113); Iskander (Bactrim) 0.9310 (95% CI 0.8122-1.0672); Iskander (Lidaprim) 0.9310 (95% CI 0.8122-1.0672); Yoon (kanamycin) 0.9142 (95% CI 0.7630-1.0954); Hira (kanamycin) 1.0280 (95% CI 0.979301.0791).